Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by SamV21on Aug 08, 2022 10:40am
94 Views
Post# 34878610

Reduvo is not approved and sold anywhere scammers !

Reduvo is not approved and sold anywhere scammers !Tetra has no money to launch Reduvo and there is another Canadian company selling  Dronimabol to Germany right now Greenrise Global's Medical Cannabis they trade at .155 and struggling , Reduvo isn't going to save Tetra .140,000,000 million deficit ,the company is only worth 25,000,000  Guy can hide money in all kinds of places for his own good. Its all hype and exaggeration from pumpers , reposting old garbage sucking people in with his any day now , its late  , nothing , Tetra has nothing and is nothing , why does everyone want to sell at .065 if this is going to be anything anytime soon ?
Dec 1, 2020 — Canadian cannabis producer Tilray is offering dronabinol in the German medical cannabis market. Once again Guy riding on the coat tails of the big boys , dreaming scamming telling us all about his exclusive science BS. ITS BEEN DONE ALREADY ! WE ARE JUST PAYING GUYS OVER PAID WAGE NOW FOR YEARS WITH NO RESULTS.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities